Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness
ANOWSM
2 other identifiers
interventional
80
1 country
1
Brief Summary
The goal of this clinical trial is to examine and compare the effect of behavioral sleep treatment: BBTI (brief behavioral treatment of insomnia) and brief mindfulness (MI), independently and combined vs control on frequency of nighttime awakenings to void (nocturia) and on nighttime urine production in older women over the age 65 years with nocturia. To study the effect of these treatments, participants will be randomly assigned to one of the following groups 1) BBTI alone, 2) MI alone, 3) BBTI+MI, or 4) control: sleep information only without any structured sleep or mindfulness therapy. The study aims to examine the effect of these therapies at end-of-treatment (week 4), as well sustained effects at 3- and 6-months. The main questions the study aims to answer are:
- 1.do these treatments reduce the frequency of nighttime awakenings to void
- 2.do these treatments reduce the volume of nighttime urine production
- 3.do these treatments improve sleep quality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedStudy Start
First participant enrolled
September 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2028
Study Completion
Last participant's last visit for all outcomes
April 30, 2029
August 12, 2026
August 1, 2026
2.1 years
August 7, 2026
August 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Nocturia
number of nighttime awakenings to void
4 weeks, 3- and 6-months post-intervention
Other Outcomes (2)
Nocturnal polyuria index (NPi)
4 weeks, 3- and 6-months post-intervention
Pittsburgh Sleep Quality Index (PSQI)
4-weeks, 3- and 6-month post intervention
Study Arms (4)
Control
OTHERBBTI
EXPERIMENTALBrief behavioral treatment of insomnia
MI
EXPERIMENTALBrief mindfulness
BBTI+MI
EXPERIMENTALBrief behavioral treatment of insomnia and brief mindfulness
Interventions
BBTI: will entail a 45- to 60-minute individual intervention session with instructions regarding sleep education and discussion of homeostatic and circadian mechanisms of human sleep regulation. This education provides the rationale for the 4 main interventions of BBTI: 1. reduce time in bed; 2. get up at the same time every day, regardless of sleep duration; 3. do not go to bed unless sleepy; and 4. do not stay in bed unless asleep
Participants in the MI group will be trained to engage in a brief mindfulness method involving body scan with acceptance language training.
The control condition is intended to emulate the behavioral treatment information generally available to patients.
Eligibility Criteria
You may qualify if:
- Female
- Age \> or =65 years
- Nocturia ≥2/night
- Poor sleep (Insomnia Severity Index ≥8)
- MoCA (including trail making) \>26
You may not qualify if:
- Conditions that affect bladder function: Multiple sclerosis, Alzheimer's disease, spinal cord injury, urethral obstruction, urinary retention, interstitial cystitis, bladder cancer, radiation to the pelvic area, bladder surgery, current or uncontrolled chronic or recurrent bowel issues, bacterial endocarditis
- cardiac or respiratory disease that limits daily function
- Unstable or acute medical condition:
- Untreated, current, severe psychiatric condition (assessed during Visit 1a- medical history)
- Post void residual ≥ 200ml- assessed during baseline visit
- Currently diagnosed and/or untreated obstructive sleep apnea, untreated restless leg syndrome, untreated parasomnia
- Untreated or poorly controlled fluid overload conditions like CHF, diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shachi Tyagi, MD, MS
University of Pittsburgh
- STUDY CHAIR
Shachi Tyagi, MD, MS
University of Pittsburgh
- STUDY DIRECTOR
Becky D Clarkson, PhD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 7, 2026
First Posted
August 12, 2026
Study Start (Estimated)
September 15, 2026
Primary Completion (Estimated)
October 30, 2028
Study Completion (Estimated)
April 30, 2029
Last Updated
August 12, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Following publication, no end date
All of the individual participant data collected during the trial, after deidentification may be shared with other researchers.